Astellas Pharma A/S

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease

Completed

Conditions: Chronic Kidney Disease Associated Anemia

Interventions: Other: Non-Interventional

First Posted Date: 2018-08-23

Last Posted Date: 2024-10-31

Lead Sponsor: Astellas Pharma a/s

Target Recruit Count: 14415

Registration Number: NCT03643601

Locations: 🇸🇪
SE46001, Stockholm, Sweden

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Completed

Conditions: Metastatic Castration Resistant Prostate Cancer

Interventions: Drug: enzalutamide
Drug: docetaxel

First Posted Date: 2017-11-01

Last Posted Date: 2024-11-21

Lead Sponsor: Astellas Pharma a/s

Target Recruit Count: 211

Registration Number: NCT03328364

Locations: 🇸🇪
Site SE46001, Malmo, Sweden

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy